3D Holo-tomographic Mapping of COVID-19 Microclots in Blood to Assess Disease Severity
Main Authors: | Talia Bergaglio, Olena Synhaivska, Peter Niraj Nirmalraj |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2024-01-01
|
Series: | Chemical & Biomedical Imaging |
Online Access: | https://doi.org/10.1021/cbmi.3c00126 |
Similar Items
-
TEG<sup>®</sup>, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
by: Gert Jacobus Laubscher, et al.
Published: (2021-11-01) -
Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
by: S Turi, et al.
Published: (2020-01-01) -
COVID-19-Related Thromboinflammatory Status: MicroCLOTS and Beyond (Editorial)
by: P. Nardelli, et al.
Published: (2020-07-01) -
MicroCLOTS pathophysiology in coronavirus disease 2019
by: Samuele Renzi, et al.
Published: (2023-07-01) -
Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID
by: Douglas B. Kell, et al.
Published: (2024-01-01)